欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-小分子抑制剂&激动剂-Cell Cycle/DNA Damage-Aurora Kinase-PF-03814735
PF-03814735

Chemical Structure : PF-03814735

CAS No.: 942487-16-3

PF-03814735 (PF 03814735)

货号: PC-49273Not For Human Use, Lab Use Only.

PF-03814735 is a potent, orally bioavailable, reversible inhibitor of both Aurora A and Aurora B kinases with IC50 values of 0.8 and 5 nM, respectively.

规格 价格 库存 数量
5 mg ¥980 In stock
10 mg ¥1480 In stock
25 mg ¥2580 In stock
50 mg ¥4280 In stock
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

生物&药学活性

PF-03814735 is a potent, orally bioavailable, reversible inhibitor of both Aurora A and Aurora B kinases with IC50 values of 0.8 and 5 nM, respectively.
PF-03814735 produced significant inhibition of several other protein kinases in recombinant kinase enzymatic assays (FAK, 22 nM; TrkA 30 nM).
PF-03814735 showed >90% inhibition at 100 nM against 19/220 kinases.
PF-03814735 markedly reduced levels of Aurora1 phosphorylated on Thr 232 in cells with IC50 of 20 nM, also inhibited the phosphorylation of histone H3 on Ser10, another marker of Aurora1 kinase activity, with an IC50 of 50 nM.
PF-03814735 inhibited Aurora2 autophosphorylated on Thr288 with IC50 of 150 nM in MDA-MB-231 tumor cell.
PF-03814735 exhibited antiproliferative effects against human cell lines from various tumor types (HCT-116, HL-60, A549, and H125) with IC50 of 42-150 nM.
Oral administration of PF-03814735 to tumor-bearing mice results in inhibition of phosphohistone H3 in vivo, PF-03814735 (20 mg/kg, i.v.)inhibited tumor growth in human xenograft mouse models HCT-116 xenografts.
The combination of PF-03814735 and docetaxel in xenograft mouse tumor models shows additive tumor growth inhibition.

物理化学性质&存储条件

分子量 474.488
分子式 C23H25F3N6O2
外观性状 Solid
CAS No.
储存条件
固体粉末
-20°C 12 个月; 4°C 6 个月
配置液
-80°C 6 个月; -20°C 6 个月
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

N-(2-((1S,4R)-6-((4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1,2,3,4-tetrahydro-1,4-epiminonaphthalen-9-yl)-2-oxoethyl)acetamide

参考文献

1. Jani JP, et al. Mol Cancer Ther. 2010 Apr;9(4):883-94.

2. Schöffski P, et al. Eur J Cancer. 2011 Oct;47(15):2256-64.

3. Hook KE, et al. Mol Cancer Ther. 2012 Mar;11(3):710-9.

备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

联系我们 sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

询单

  • *产品名称:
  • *姓名:
  • *邮箱:
  • *公司名称:
  • *询单数量:
  • *国籍:
  • 询单信息: